References: 1. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:1-9. 2. DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. https://www.cdc.gov/pcd/issues/2014/13_0415.htm. Accessed May 1, 2018. 3. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009;9(55):1-10. 4. Ko JY, Rockhill KM, Tong VT, et al. Trends in postpartum depressive symptoms—27 states, 2004, 2008, and 2012. MMWR. 2017;66(6):153-156. https://www.cdc.gov/mmwr/volumes/66/wr/mm6606a1.htm. Accessed May 1, 2018. 5. Reddy UM, Rice MM, Grobman WA, et al. Serious maternal complications after early preterm delivery (24-33 weeks’ gestation). Am J Obstet Gynecol. 2015;213(4):538.e1-e9.
Terms and Conditions for Using this Site
© 2018 MediMedia, an ICON plc company.
All Rights Reserved.
© 2018 Sage Therapeutics, Inc. All rights reserved.
PP-US-PPD-0022 May 2018
This website is funded by Sage Therapeutics. All content is maintained by and property of Sage Therapeutics.